medigraphic.com
ISSN 1028-9933 (Electronic)

2022, Number 4

<< Back Next >>

RIC 2022; 101 (4)

Prognostic factors associated with the survival of patients with astrocytic tumors

Castellanos-Bertot Y, Hodelín-Tablada R

Language: Spanish
References: 27
Page: 1-14
PDF size: 895.00 Kb.


ABSTRACT

Introduction: Brain tumors are a heterogeneous group given the different cells that originate them. The most frequent brain tumors are those derived from the glia, with astrocytomas being the most common.
Objective: To systematize the findings of studies that examined multiple prognostic factors for survival in patients with astrocytoma-type brain tumors.
Method: a systematic review of observational, analytical, prospective studies was carried out. The bibliographic search was carried out in the electronic databases Medline, SciELO, LILACS, PubMed and Google Scholar, with the following descriptive terms: age, sex, prognostic factors, brain cancer, astrocytoma.
Results: The search found 136,452 articles that were distributed in different databases. When applying the eligibility criteria, 13 articles remained for analysis. In the case of prognostic factors dependent on the lesion, tumor or disease, most researches showed a tendency to evaluate the histologic grade and the histology of the lesion. In the case of the patient-dependent prognoses, there was a greater inclination towards age, sex and the symptoms presented, while in those dependent on the treatment, the treatment modalities suggested to the patients were shown indistinctly: surgery, chemotherapy and radiotherapy.
Conclusions: In this research, the main prognostic factors contained in the literature about patients with astrocytic tumors were presented, which are grouped into prognostic factors depending on the tumor, the patient and the treatment. These must be taken into account to evaluate the patient with these brain tumor lesions.


REFERENCES

  1. Contreras LE. Epidemiología de tumores cerebrales. Rev Méd Clín Las Condes [Internet]. 2017 Mayo-Jun [citado 30/01/2022]; 28(3):332-8. DOI: https://doi.org/10.1016/j.rmclc.2017.05.0011.

  2. López-Aguilar E, Sepúlveda Vildósola AC, Rioscovián-Soto AP, Gascón-Lastiri G, Rojas-Puentes F, Siordia-Reyes G, et al. Sobrevida de los pacientes con astrocitoma de alto grado que expresan el antígeno Ki67, atendidos en un hospital de pediatría. Gac Méd Méx [Internet]. 2010 [citado 12/07/2022]; 146(2). Disponible en: https://www.medigraphic.com/pdfs/gaceta/gm-2010/gm102g.pdf2.

  3. Gomez-Vega JC, Ocampo-Navia MI, De Vries E, Feo-Lee O. Epidemiología de los tumores cerebrales en colombia, un periodo de 10 años. Neuroc J [Internet]. 2018 [citado 03/01/2022]; 25(3):7-21. Disponible en: https://www.neurocienciasjournal.com/index.php/neurocienciasjournal/article/view/843.

  4. García Escribano Y, Nuño López I, Llanos Muñoz M, Ceballos Lenza I. Estudio epidemiológico y pronóstico de tumores cerebrales de alto grado en el Hospital Universitario de Canarias [Internet]. Canarias: Universidad de La Laguna; 2016. [citado 03/01/2022]. Disponible en: https://bit.ly/3xvwDfw4.

  5. Martínez-Garcia M, Álvarez-Linera J, Carrato C, Ley L, Luque R, Maldonado X, et al. SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017). Clin Transl Oncol [Internet]. 2018 [citado 12/07/2022]; 20(1):22-8. DOI: https://doi.org/10.1007/s12094-017-1763-65.

  6. Alegría-Loyola MA, Galnares-Olalde JA, Mercado M. Tumores del sistema nervioso central. Rev Med Inst Mex Seg Soc [Internet]. 2017 [citado 03/01/2022]; 55(3):330-40. Disponible en: https://www.redalyc.org/journal/4577/457750970009/457750970009.pdf6.

  7. ASATE. Guía sobre los tumores cerebrales [Internet]. Madrid: Asociación de Afectador por Tumores Cerebrales en España; 2011. Disponible en: http://www.asate.es/wp-content/uploads/Guia-para-afectados-por-Tumores-Cerebrales.pdf7.

  8. Dirección Nacional de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2018 [Internet]. La Habana: Minsap; 2019. [citado 12/07/2022]. Disponible en: https://files.sld.cu/bvscuba/files/2019/04/Anuario-Electr%C3%B3nico-Espa%C3%B1ol-2018-ed-2019-compressed.pdf8.

  9. Contreras LE. Epidemiología de tumores cerebrales. Rev Méd Clín Las Condes [Internet]. 2017 [citado 14/09/2021]; 28(3):332-338. DOI: https://doi.org/10.1016/j.rmclc.2017.05.0019.

  10. Salas S, Agut T, Rovira C, Cañizo D, Lavarino C, García Alix A. Glioblastoma multiforme congénito infratentorial. Un tumor excepcional con una biología aún desconocida. Rev Neurol [Internet]. 2016 [citado 14/09/2021]; 63:411-4. DOI: https://doi.org/10.33588/rn.6309.201620810.

  11. Elzaurdín Mora RA, Lara Fernández N. Uso de nimotuzumab en paciente con astrocitoma anaplásico. Rev Cubana Med [Internet]. 2019 Dic [citado 02/12/2021]; 58(4):e507. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232019000400008&lng=es11.

  12. Uclés Villalobos V, Segura Corrales P, Espinoza Reyes RA. Rehabilitación del paciente con tumor cerebral. Rev Clín Esc Med Univ Costa Rica [Internet]. 2018 [citado 24/09/2021]; 8(5):1-18. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=8417012.

  13. Xu CQ, Yao F, Mohamad Y, Wong R, Kent D, Seetharaman S, et al. Evaluating the Associations Between the Liver Frailty Index and Karnofsky Performance Status With Waitlist Mortality. Transplant Direct [Internet]. 2021 Jan [citado 22/02/2022]; 7(2):e651. DOI: https://dx.doi.org/10.1097%2FTXD.000000000000109713.

  14. Chi Ramírez D, Cho Rivas I, León González R, Díaz Martínez JR, Alert Silva J, Pestana Knight EA, et al. Factores relacionados con la supervivencia de pacientes con tumores cerebrales tratados con cirugía y radioterapia. Rev Oncol Ecu [Internet]. 2006 Jun [citado 08/02/2022]; 16:1-2. Disponible en: http://www.roe-solca.ec/index.php/johs/article/view/33814.

  15. de Araujo OL, da Trindade KM, Trompieri NM, Fontenele JV, Felix FHC. Análise de sobrevida e fatores prognósticos de pacientes pediátricos com tumores cerebrais. J Pediatr [Internet]. 2011 [citado 08/02/2022]; 87(5):425-432. DOI: https://doi.org/10.1590/S0021-7557201100050001015.

  16. Brossard Alejo JS, Núñez Ferrer P, Rodríguez Herrera E, Agustín Antomarchi LM, Romero García LI. Survival of the children population with tumors of the central nervous system. MEDISAN [Internet]. 2011 Ene [citado 08/02/2022]; 15(1):23-32. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192011000100004&lng=es16.

  17. Jung K-W, Yoo H, Kong H-J, Won Y-J, Park S, Lee SH. Population-based survival data for brain tumors in Korea. J Neuro- Oncol [Internet]. 2012 Jun [citado 08/02/2022]; 109(2):301-307. DOI: https://doi.org/10.1007/s11060-012-0893-517.

  18. López-Aguilar E, Rioscovian-Soto A, Betanzos-Cabrera Y, Ruiz-Esparza R, Sepúlveda-Vildósola A. Alteraciones cromosómicas y supervivencia en pacientes con astrocitomas. Rev Med Inst Mex Seg Soc [Internet]. 2014 [citado 08/02/2022]; 52(Supl 2):S98-103. Disponible en: https://www.medigraphic.com/pdfs/imss/im-2014/ims142r.pdf18.

  19. Alonso D, Matallanas M, Riveros-Pérez A, Pérez-Payo M, Blanco S. Factores pronósticos y predictivos en gliomas de alto grado. Experiencia en nuestro centro. Neurocirugía [Internet]. 2017 [citado 08/02/2022]; 28(6):276-283. DOI: https://doi.org/10.1016/j.neucir.2017.07.00519.

  20. Nizamutdinov D, Stock EM, Dandashi JA, Vasquez EA, Mao Y, Dayawansa S, et al. Prognostication of Survival Outcomes in Patients Diagnosed with Glioblastoma. World Neuros [Internet]. 2018 Jan [citado 08/02/2022]; 109:e67-74. DOI: https://doi.org/10.1016/j.wneu.2017.09.10420.

  21. Gittleman H, Boscia A, Ostrom QT, Truitt G, Fritz Y, Kruchko C, Barnholtz-Sloan JS. Survivorship in adults with malignant brain and other central nervous system tumor from 2000-2014. Neuro Oncol [Internet]. 2018 Nov [citado 12/07/2022]; 20(suppl 7):vii6-vii16. DOI: https://doi.org/10.1093/neuonc/noy09021.

  22. Mateo-Sierra O, Alcalá-Torres J, Serret-De Troya C, Valera-Melé M, Solá-Vendrell E. Análisis del impacto clínico de la reclasificación diagnóstica de gliomas cerebrales según la clasificación de la Organización Mundial de la Salud (2016). Rev Neurol [Internet]. 2019 [citado 08/02/2022]; 69(10):402-408. DOI: https://doi.org/10.33588/rn.6910.201925622.

  23. Vera Ponce VJ, Méndez Aguilar P. Factores pronóstico de supervivencia en adultos por gliomas de alto grado en un hospital de Lima, Perú. Rev Fac Med Hum [Internet]. 2020 [citado 08/02/2022]; 20(3):16. Disponible en: http://inicib.urp.edu.pe/rfmh/vol20/iss3/1623.

  24. White ML, Zhang Y, Jaffar Kazmi SA, Aizenberg M, Shonka N, Yu F, et al. Evaluating survival in subjects with astrocytic brain tumors by dynamic susceptibility-weighted perfusion MR imaging. PLoS ONE [Internet]. 2021 [citado 08/02/2022]; 16(1):e0244275. DOI: https://doi.org/10.1371/journal.pone.024427524.

  25. Mladenovsk M, Valkov I, Ovcharov M, Vasilev N, Duhlenski I. High grade glioma surgery-clinical aspects and prognosis. Folia Med (Plovdiv) [Internet]. 2021 [citado 08/02/2022]; 63(1):35-41. DOI: https://doi.org/10.3897/folmed.63.e5525525.

  26. Aiura R, Nakayama S, Yamaga H, Kato Y, Fujishima H. Systemic thromboembolism in cluding multiple cerebral infarctions with middle cerebral artery occlusion caused by the progression of adenomyosis with benign gynecological tumor: a case report. BMC Neurol [Internet]. 2021 Jan [citado 08/02/2022]; 21(1):4. DOI: https://doi.org/10.1186/s12883-021-02045-726.

  27. Sinning M. Clasificación de los tumores cerebrales. Rev Méd Clín Las Condes [Internet]. 2017 Mayo [citado 04/02/2022]; 28(3):339-342. DOI: https://doi.org/10.1016/j.rmclc.2017.05.00227.




2020     |     www.medigraphic.com